ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
Wu FQ, Fang T, Yu LX, Lv GS, Lv HW, Liang D, Li T, Wang CZ, Tan YX, Ding J, Chen Y, Tang L, Guo LN, Tang SH, Yang W, Wang HY.
Wu FQ, et al. Among authors: lv gs, lv hw.
J Hepatol. 2016 Aug;65(2):314-24. doi: 10.1016/j.jhep.2016.04.019. Epub 2016 May 3.
J Hepatol. 2016.
PMID: 27154061